Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin vs prulifloxacin for infectious acute exacerbation of COPD after prior antibiotic failure
2008-003842-27Phase 4Completed
- Sponsor
- Fondazione FADOI
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in chronic obstructive pulmonary disease (COPD) comparing Levofloxacin with Prulifloxacin (2 arms). Primary endpoint: Therapeutic success at end of treatment. Started Mar 2009; status: completed.
02
Drugs
levofloxacinprulifloxacin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2008-003842-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003842-27.